DE69610716D1 - Topiramate-immunoassay, sowie analoge und antikörper - Google Patents
Topiramate-immunoassay, sowie analoge und antikörperInfo
- Publication number
- DE69610716D1 DE69610716D1 DE69610716T DE69610716T DE69610716D1 DE 69610716 D1 DE69610716 D1 DE 69610716D1 DE 69610716 T DE69610716 T DE 69610716T DE 69610716 T DE69610716 T DE 69610716T DE 69610716 D1 DE69610716 D1 DE 69610716D1
- Authority
- DE
- Germany
- Prior art keywords
- topiramate
- immunoassay
- antibodies
- analogs
- add
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
- C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
- C07H9/04—Cyclic acetals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/9473—Anticonvulsants, e.g. phenobarbitol, phenytoin
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/815—Test for named compound or class of compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Analytical Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/565,143 US5952187A (en) | 1995-12-01 | 1995-12-01 | Topiramate immunoassay |
PCT/US1996/018971 WO1997019950A1 (en) | 1995-12-01 | 1996-11-27 | Topiramate immunoassay, as well as analogs and antibodies |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69610716D1 true DE69610716D1 (de) | 2000-11-23 |
DE69610716T2 DE69610716T2 (de) | 2001-05-10 |
Family
ID=24257371
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69610716T Expired - Lifetime DE69610716T2 (de) | 1995-12-01 | 1996-11-27 | Topiramate-immunoassay, sowie analoge und antikörper |
Country Status (9)
Country | Link |
---|---|
US (1) | US5952187A (de) |
EP (1) | EP0876385B1 (de) |
JP (1) | JP4435305B2 (de) |
AT (1) | ATE197052T1 (de) |
AU (1) | AU721665B2 (de) |
CA (1) | CA2239224C (de) |
DE (1) | DE69610716T2 (de) |
ES (1) | ES2153134T3 (de) |
WO (1) | WO1997019950A1 (de) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0019593D0 (en) * | 2000-08-10 | 2000-09-27 | Norgine Europe Bv | Production of bile acid derivatives |
UA78211C2 (en) * | 2001-07-09 | 2007-03-15 | Ortho Mcneil Pharm Inc | Salts of fructopyranose derivatives as anticonvulsant |
DE60222423T2 (de) | 2001-07-13 | 2008-06-19 | Diachemix Llc, Milwaukee | Auf fluoreszenzpolarisation beruhender homogener assay für aflatoxine |
US20100311701A1 (en) * | 2002-02-15 | 2010-12-09 | Transform Pharmaceuticals, Inc | Pharmaceutical Co-Crystal Compositions |
US7927613B2 (en) | 2002-02-15 | 2011-04-19 | University Of South Florida | Pharmaceutical co-crystal compositions |
US7790905B2 (en) * | 2002-02-15 | 2010-09-07 | Mcneil-Ppc, Inc. | Pharmaceutical propylene glycol solvate compositions |
US20090088443A1 (en) * | 2002-02-15 | 2009-04-02 | Julius Remenar | Novel crystalline forms of conazoles and methods of making and using the same |
US6559293B1 (en) * | 2002-02-15 | 2003-05-06 | Transform Pharmaceuticals, Inc. | Topiramate sodium trihydrate |
EP1494998A2 (de) | 2002-03-01 | 2005-01-12 | University Of South Florida | Mehrkomponenten festphasen enthaltend wenigstens einen pharmazeutischen wirkstoff |
US7060725B2 (en) * | 2002-05-13 | 2006-06-13 | Janssen Pharmaceutica N.V. | Substituted sulfamate anticonvulsant derivatives |
US20070059356A1 (en) * | 2002-05-31 | 2007-03-15 | Almarsson Oern | Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen |
CA2489984A1 (en) * | 2002-06-21 | 2003-12-31 | Transform Pharmaceuticals, Inc. | Pharmaceutical compositions with improved dissolution |
US8183290B2 (en) | 2002-12-30 | 2012-05-22 | Mcneil-Ppc, Inc. | Pharmaceutically acceptable propylene glycol solvate of naproxen |
WO2005088307A1 (en) * | 2004-03-10 | 2005-09-22 | Seradyn Inc. | Immunoassays for everolimus |
US7638291B2 (en) * | 2004-10-25 | 2009-12-29 | Seradyn, Inc. | Immunoassays for topiramate |
US20060088886A1 (en) * | 2004-10-25 | 2006-04-27 | Anlong Ouyang | Topiramate analogs |
EP2061458B1 (de) * | 2006-09-15 | 2014-12-10 | Regents of the University of Minnesota | Topiramatzubereitungen und verfahren zu ihrer verwendung |
US20090239942A1 (en) * | 2006-09-15 | 2009-09-24 | Cloyd James C | Topiramate Compositions and Methods of Making and Using the Same |
EP2261259B1 (de) * | 2009-06-10 | 2014-07-30 | Randox Laboratories Ltd. | Immunoassay für N-(3-chlorphenyl)piperazin-basierte Antidepressiva |
US8652527B1 (en) | 2013-03-13 | 2014-02-18 | Upsher-Smith Laboratories, Inc | Extended-release topiramate capsules |
US9101545B2 (en) | 2013-03-15 | 2015-08-11 | Upsher-Smith Laboratories, Inc. | Extended-release topiramate capsules |
CN110655542A (zh) * | 2018-06-29 | 2020-01-07 | 鲁南制药集团股份有限公司 | 一种2,3:4,5-双-O-(1-甲基亚乙基)-β-D-吡喃果糖氯磺酸酯的晶型 |
CN114685526A (zh) * | 2020-12-25 | 2022-07-01 | 长沙博源医疗科技有限公司 | 一种托吡酯衍生物、免疫原、抗托吡酯特异性抗体及其制备方法与应用 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU555213B2 (en) * | 1981-02-17 | 1986-09-18 | Abbott Laboratories | N-substituted-amido-fluoresein derivatives |
US4668640A (en) * | 1981-12-11 | 1987-05-26 | Abbott Laboratories | Fluorescence polarization immunoassay utilizing substituted carboxyfluoresceins |
US4492762A (en) * | 1981-12-11 | 1985-01-08 | Abbott Laboratories | Fluorescent polarization immunoassays |
EP0218010A3 (de) * | 1985-07-10 | 1988-01-07 | Abbott Laboratories | Verfahren zur Bestimmung von Liganden und substituierte Carboxyfluoreszein-Markers zur Durchführung desselben |
US4751190A (en) * | 1985-07-22 | 1988-06-14 | Abbott Laboratories | Fluorescence polarization immunoassay and reagents for use therein |
US5051361A (en) * | 1988-10-19 | 1991-09-24 | Sigma Chemical Company | AZT immunoassays, derivatives, conjugates and antibodies |
US5258402A (en) * | 1992-06-11 | 1993-11-02 | Mcneil-Ppc, Inc. | Imidate derivatives of pharmaceutically useful anticonvulsant sulfamates |
US5384327A (en) * | 1992-12-22 | 1995-01-24 | Mcneilab, Inc. | Anticonvulsant sorbopyranose sulfamates |
-
1995
- 1995-12-01 US US08/565,143 patent/US5952187A/en not_active Expired - Lifetime
-
1996
- 1996-11-27 CA CA002239224A patent/CA2239224C/en not_active Expired - Fee Related
- 1996-11-27 AT AT96942815T patent/ATE197052T1/de not_active IP Right Cessation
- 1996-11-27 DE DE69610716T patent/DE69610716T2/de not_active Expired - Lifetime
- 1996-11-27 AU AU11416/97A patent/AU721665B2/en not_active Ceased
- 1996-11-27 WO PCT/US1996/018971 patent/WO1997019950A1/en active IP Right Grant
- 1996-11-27 EP EP96942815A patent/EP0876385B1/de not_active Expired - Lifetime
- 1996-11-27 JP JP52064297A patent/JP4435305B2/ja not_active Expired - Lifetime
- 1996-11-27 ES ES96942815T patent/ES2153134T3/es not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP4435305B2 (ja) | 2010-03-17 |
AU721665B2 (en) | 2000-07-13 |
AU1141697A (en) | 1997-06-19 |
US5952187A (en) | 1999-09-14 |
ES2153134T3 (es) | 2001-02-16 |
CA2239224A1 (en) | 1997-06-05 |
DE69610716T2 (de) | 2001-05-10 |
JP2000502888A (ja) | 2000-03-14 |
EP0876385B1 (de) | 2000-10-18 |
CA2239224C (en) | 2006-11-14 |
EP0876385A1 (de) | 1998-11-11 |
WO1997019950A1 (en) | 1997-06-05 |
ATE197052T1 (de) | 2000-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69610716D1 (de) | Topiramate-immunoassay, sowie analoge und antikörper | |
DK261386A (da) | Monoklonale antistoffer | |
FI102017B (fi) | Elektrokemoluminoivat analyysimenetelmät | |
DE69407402D1 (de) | Repamycinbestimmung | |
EP0375422A3 (de) | Zusammensetzung und Methoden zur Bestimmung der Anwesenheit von Amphetaminen in einer Probe, die in Verdacht steht, Amphetamine und/oder Metamphetamine zu enthalten | |
MY104946A (en) | Antigen antibody conjugate. | |
ES2181734T3 (es) | Ensayo inmunologico de ciclosporina. | |
DE68922243D1 (de) | Immuntest für HIV-1-Antigene unter Benutzung von F(AB')2-Fragmenten als Sonde. | |
CA2172663A1 (en) | Improved reagents for a cannabinoid immunoassay | |
ATE112059T1 (de) | Verfahren zur bestimmung eines analyten. | |
DE69403484D1 (de) | Prüfungskit | |
CA2246896A1 (en) | Immunoassay utilizing two incubations with labelled antigen | |
DE3884731D1 (de) | Monoklonaler Antikörper gegen Methamphetamin, seine Herstellung, Testverfahren und Testsatz für Methamphetamin. | |
FR2599513B1 (fr) | Anticorps monoclonaux inhibant la liaison de ige soluble aux lymphocytes humains, hybridomes monoclonaux produisant de tels anticorps, leur utilisation | |
FI86255B (fi) | Monoklonal antiurokinase-antikropp, den innehaollande matris och biokemiska testpackningar, i vilka den anvaendes. | |
PH21459A (en) | Process for assaying atl virus antibody and reagent therefor | |
DE69922680D1 (de) | Detektion und quantifikation von vancomycin in den biologischen flüssigkeiten | |
MX9704717A (es) | Antigeno, anticuerpos y ensayo de diagnostico para la enfermedad de alzheimer. | |
TW288020B (en) | Monoclonal antibodies specific to methamphetamine, hybridoma producing the antibodies, kits containing the antibodies and uses thereof | |
JPS5386014A (en) | Quantitative analysis of antigen and antibody | |
HUP9701386A2 (hu) | Immunológiai vizsgálati eljárás | |
DK0964875T3 (da) | Antistof specifikt for 5-hydroxytryptophol eller et konjugat deraf samt immunoassay til bestemmelse af 5-hydroxytryptophol eller konjugater deraf | |
DE59913439D1 (de) | Anti-petasin-antikörper, verfahren zu ihrer herstellung und ihre verwendung | |
ATE299374T1 (de) | Adenosine als antithrombosemittel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8327 | Change in the person/name/address of the patent owner |
Owner name: SERADYN, INC., INDIANAPOLIS, IND., US |
|
8364 | No opposition during term of opposition |